Chandra Bhagat Pharma logo

Chandra Bhagat Pharma financials and balance sheet

BSE: 542934Pharmaceuticals & BiotechnologySmall Cap

Last close ₹39.00down ₹1.00 (2.50%)

Share price at the BSE close on 23 Oct 2026. Previous close ₹40.00.

52-week range of traded prices to 23 Oct 2026
₹29.70Low, 6 May 2026₹52.99High, 22 Sep 2026
Market cap
₹29 Cr3,869th largest listed
P/E
10.4
P/B
0.9
Dividend yield
Nonein the last 12 months
ROE
9.0%
Debt to equity
0.50
Volume, BSE
2,000

7 years at a glance

Standalone: the listed company alone, without its subsidiaries. ₹ crore, years to March.Chandra Bhagat Pharma annual reports

Revenue, net profit and borrowings, ₹ crore

  • Revenue
  • Net profit
  • Borrowings
Peak revenue ₹221 Cr, year to Mar 2024

Operating and net margin, per cent

  • Operating margin
  • Net margin

Results for the year to Mar 2026

Standalone: the listed company alone, without its subsidiaries. ₹ crore.

From revenue to net profit

  1. Revenue116
  2. Materials and goods−94
  3. Employee costs−3.0
  4. Other expenses−16
  5. Operating profit3.8
  6. Depreciation−1.0
  7. Other income+3.4
  8. Finance costs−2.0
  9. Profit before tax4.1
  10. Tax−1.1
  11. Net profit3.0

What the company owns

  • Receivables₹55 Cr
  • Plant, investments and other assets₹30 Cr
  • Inventory₹5 Cr
  • Cash and bank₹3 Cr
  • Current investments₹2 Cr

What pays for it: net worth and liabilities

  • Net worth₹33 Cr
  • Owed to suppliers₹32 Cr
  • Borrowings₹17 Cr
  • Other liabilities₹13 Cr

Profit and loss

Standalone, ₹ crore, years to March.Chandra Bhagat Pharma half-yearly results

₹ croreMar 2020Mar 2021Filed 6 JulMar 2022Filed 7 JunMar 2023Filed 23 MayMar 2024Filed 8 AugMar 2025Filed 29 MayMar 2026Filed 25 May
Revenue from operations94719412022187116
91–9111722988112
Materials and goods bought8660811072087394
Employee costs2–2–333
Other expenses3–8–181216
Operating profit before depreciation3–33−7−24
Operating margin3.3%–2.8%2.6%−3.3%−1.8%3.3%
Materials, % of revenue91.3%–86.5%–94.0%84.5%80.5%
Employee costs, % of revenue2.6%–1.8%–1.2%2.9%2.6%
Other expenses, % of revenue2.8%–8.9%–8.0%14.3%13.6%
Depreciation and amortisation0–00011
Operating profit after depreciation3–33−8−23
Other income00201163
Finance costs3332122
Profit before tax0011214
0000101
Net profit0011213
Net margin0.3%0.3%0.8%0.8%0.7%1.0%2.6%
Materials, employee costs and other expenses are shown for the years they add up to operating expenses; for the year to Mar 2023 they do not, so they are left blank. Operating expenses, operating profit before depreciation and operating profit after depreciation are left blank for the year to Mar 2021: the statement does not state its depreciation, which operating profit is worked out from, so operating profit is not given.

Balance sheet

Standalone, ₹ crore, at 31 March.

₹ croreMar 2021Filed 6 JulMar 2022Filed 7 JunMar 2023Filed 23 MayMar 2024Filed 8 AugMar 2025Filed 29 MayMar 2026Filed 25 May
262727293033
Share capital888888
Reserves181920212226
252019162117
333827716958
1386223
Total assets72726110210294
222447
707159989788
Net debt221412112012
Borrowings are counted again inside the liabilities due within a year and after a year. No balance sheet is on record for the year to Mar 2020, so its lines and the ratios worked from it are blank there.

Cash flow

Standalone, ₹ crore, years to March.

₹ croreMar 2021Filed 6 JulMar 2022Filed 7 JunMar 2023Filed 23 MayMar 2024Filed 8 AugMar 2025Filed 29 MayMar 2026Filed 25 May
7.712.55.36.2−5.79.2
7.812.65.66.6−7.19.2
4.08.42.12.5−9.04.1
Receivables−1.40.46.8−31.33.5−18.7
Inventories8.81.05.120.48.0−4.0
Payables0.4−10.20.410.1−4.322.9
Other working capital−3.717.2−10.23.2−16.23.8
Tax paid−0.1−0.1−0.2−0.5−0.6−0.4
Interest paid0.00.00.00.01.92.0
Capital spending0.00.10.42.31.20.9
Free cash flow7.712.44.93.9−6.98.3
0.10.1−0.1−1.9−0.8−0.4
−5.4−9.6−4.4−5.82.2−6.4
Dividends paid0.00.00.00.00.00.0
Shares issued0.00.00.00.00.00.0
Net change in cash2.42.90.8−1.5−4.32.4
Capital spending is part of cash from investing, and dividends paid, shares bought back and shares issued are part of cash from financing. Each is shown as an amount on a line of its own, and the section's other items are in its total only. No cash flow statement is on record for the year to Mar 2020.

Per share

Standalone, ₹ per share, years to March.

₹ per shareMar 2020Mar 2021Filed 6 JulMar 2022Filed 7 JunMar 2023Filed 23 MayMar 2024Filed 8 AugMar 2025Filed 29 MayMar 2026Filed 25 May
Earnings per share₹0.55₹0.25₹1.06₹1.20₹2.03₹1.14₹4.04
Diluted earnings per share₹0.55₹0.25₹1.06₹1.20₹2.03₹1.14₹4.04
Book value per share–₹34.30₹35.35₹36.42₹38.45₹39.72₹43.90
Shareholder yield–0.0%0.0%0.0%0.0%0.0%0.0%
Market cap at the year end (₹ crore)30.229.985.973.271.739.523.0
RatioMar 2020Mar 2021Filed 6 JulMar 2022Filed 7 JunMar 2023Filed 23 MayMar 2024Filed 8 AugMar 2025Filed 29 MayMar 2026Filed 25 May
Revenue growth–−24.8%33.1%27.2%85.0%−60.8%34.1%
Operating profit growth–––22.2%–––
Net profit growth–−39.7%319.8%13.7%69.0%−43.9%255.1%
Earnings per share growth–−54.5%324.0%13.2%69.2%−43.8%254.4%
–0.7%3.0%3.3%5.4%2.9%9.7%
––2.3 pts0.3 pts2.1 pts−2.5 pts6.7 pts
From the net margin––1.6 pts−0.3 pts−0.3 pts2.3 pts4.8 pts
From asset turnover––0.8 pts1.0 pts1.6 pts−5.3 pts3.0 pts
From borrowing––0.0 pts−0.4 pts0.8 pts0.5 pts−1.1 pts
Return on capital employed––5.5%6.6%−16.9%−4.7%5.6%
Cash conversion–4,051.9%1,564.2%581.4%403.6%−665.5%303.2%
Interest cover1.0–0.81.4––1.4
Debt to equity–0.970.740.690.570.700.50
Receivable days–80582565151171
Inventory days–21515310015318
Payable days–––––45124
Cash conversion cycle, days–––––11065
Working capital days–25816012361194120
Asset turnover–0.981.301.802.730.851.19
Assets per rupee of net worth–2.772.742.462.873.453.10
Sales per rupee of plant–167.25198.89164.4387.7733.0844.31
Capital spending to depreciation––2.643.324.681.360.89
Interest cover is left blank for the years to Mar 2024 and Mar 2025: operating profit after depreciation is a loss, and a loss covers no interest bill. No balance sheet is on record for the year to Mar 2020, so its lines and the ratios worked from it are blank there.

Growth and returns over 3, 5 and 10 years

Standalone: the listed company alone, without its subsidiaries. Each window ends with the year to Mar 2026.

Return on assets, latest year
3.1%
Cash from operations against operating profit
244.1%
Measure5 years3 years
Revenue growth, yearly rate10.5%−1.0%
Profit growth, yearly rate74.2%49.8%
Return on equity, average4.9%6.0%
Return on capital employed, average−0.8%−5.4%
Operating margin, average0.7%−0.6%
Net margin, average1.2%1.4%
Asset turnover, average1.571.59
Cash conversion cycle, days, average–88
Debt to equity, average0.640.59

Where the cash came from and went

Standalone: the listed company alone, without its subsidiaries. ₹ crore, added up over each window, which ends with the year to Mar 2026.

₹ crore5 years3 yearsLatest year
Cash from operations27.49.79.2
Cash from investing−3.0−3.1−0.4
Cash from financing−24.0−10.0−6.4
Capital spending4.94.40.9
Dividends paid0.00.00.0
Shares issued for cash0.00.00.0
Borrowings raised4.44.40.3
Borrowings repaid17.99.04.6

Accounting checks

Standalone, years to March. Published tests of whether reported profit is backed by cash and the balance sheet.

CheckMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Receivables growth less revenue growthOur threshold 0 percentage points––−35.76−72.65296.9151.9517.86
Inventory growth less cost-of-goods growthOur threshold 0 percentage points––−38.98−45.87−165.35−27.25547.58
Other current assets growth less revenue growthOur threshold 5 per cent of revenue––−1.03−0.4813.3817.66−31.31
Effective tax ratePublished threshold 17.16 per cent25.5931.9227.3322.0732.3526.3925.79
Tax charged less tax paid, % of profitOur threshold 10 percentage points––17.682.0712.18−21.4816.02
A threshold marked as ours has no published figure; it is the line we read the check against.

Credit ratings

An agency's view of the chance the company repays a borrowing on time, from AAA, the highest, down to D, in default.

DateAgencyBorrowing ratedRatingOutlookAmount, ₹ Cr
25 Sep 2026CARE Ratings Limited (opens in a new tab)Fund-based - LT/ ST-CC/Packing CreditLong and short-term scalesCARE BB / CARE A4New, NewStable16.25
25 Sep 2026CARE Ratings Limited (opens in a new tab)LT/ST Fund-based/Non-fund-based-CC/WCDL/OD/LC/BGLong and short-term scalesCARE BB / CARE A4New, NewStable23.75
16 Jul 2026CARE Ratings Limited (opens in a new tab)Fund-based - LT-Cash CreditLong-term scaleWithdrawnWithdrawn
16 Jul 2026CARE Ratings Limited (opens in a new tab)Non-fund-based - ST-BG/LCShort-term scaleWithdrawnWithdrawn
The latest rating on each borrowing. The agency's name opens its reasoning for the rating.